We touch the eye, but only the white part, the conjunctiva, for around 5 seconds...
Category: Science
The artificial pancreas is better at controlling night time blood sugar levels than conventional pump therapy according to two knew studies carried out at the Wellcome Trust clinical research facility at Addenbrooke’s Hospital in England....
Sanofi-aventis and Columbia University Medical Center announced a three-year research collaboration for the development of innovative diabetes medicines. This research collaboration, with the laboratory of Dr. Gerard Karsenty, will investigate the role of the osteoblast-secreted peptide, osteocalcin, in diabetes management...
XOMA Ltd. announced that its phase 2b trial of XOMA 052 in type 2 diabetes patients did not achieve the primary endpoint of reduction of HbA1c after six monthly treatments with XOMA 052 compared to placebo.
Biological activity of XOMA 052 supporting its potential...
Pluristem Therapeutics, Inc., an Israeli based company developing placenta-based cell therapies, and New York University (NYU) Medical Center today announced the formation of a partnership to study the use of Pluristem’s proprietary placenta-derived PLX cells for the treatment of diabetic foot ulcers...
GlaxoSmithKline and Tolerx, Inc's Investigatinal immunotherapy, Otelixizumab, for type 1 diabetes failed to meet primary end point in the Phase 3 DEFEND-1 study. Otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide...
Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans...
Harvard University and Hebrew University scientists have developed a low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns.
Several proteins, called growth factors, have been found to speed up the healing process, however purifying these growth factor proteins is very expensive, and they do not last long on the injured site....
While the causes and triggers of type 1 diabetes remain unknown, researchers from Australia have found a link between type 1 diabetes and enteroviruses, which can lead to cold, flu and even meningitis. The researchers conducted an analysis of a number of studies and found that children with type 1 diabetes are almost 10 times more likely...
JDRF and Eli Lilly signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate the insulin-producing cells destroyed by the disease. The goal of this research agreement is to understand how selected cells can be reprogrammed in order to convert them into insulin-producing cells in the body. This research is an example of regenerative medicine...